Navigation Links
Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both,Traditional and Non-traditional Migraine Symptoms

uct containing naproxen, nor in patients with asthma and nasal polyps in whom aspirin or other NSAIDs induce an exacerbation of asthma. Patients who have a history of peptic ulcer or gastrointestinal bleeding, kidney problems, uncontrolled hypertension or heart failure should consult a physician before using naproxen-containing medications. NSAIDs may cause increased risk of serious cardiovascular thrombotic events, myocardial infarction and stroke. This risk may increase with duration of use and in patients with cardiovascular disease or risk factors for cardiovascular disease. Serious gastrointestinal toxicity such as bleeding, ulceration and perforation can occur at any time in patients treated chronically with NSAID therapy and physicians should remain alert for such effects even in the absence of previous GI tract symptoms. Patients who are pregnant or are nursing should consult a physician before use of a naproxen-containing medication.

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For detailed company information, see GlaxoSmithKline's website: http://www.gsk.com .

About POZEN

POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of acute and chronic pain, migraine and other pain related conditions. POZEN is also exploring the development of product candidates in other pain-related therapeutic areas. POZEN has a development and a commercialization alliance with GlaxoSmithKline. The company's common stock is traded on The Nasdaq Stock Marke
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
2. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
3. Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA
4. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
5. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
6. Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show
7. Copaxone Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
8. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
9. New Study Demonstrates that Lubiprostone May Improve Symptom Relief Rates in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
10. New Phase IV Clinical Study Indicates LidoSite Provides Rheumatology Patients Superior Pain Relief
11. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
Post Your Comments:
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
(Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... report, "Amaranth Seed Oil Market by Extraction type (SFE, ... (Cosmetic & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & ... published by MarketsandMarkets, defines and segments the Amaranth ... of the market size in terms of value. ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... 2011 Fukuda Denshi USA has announced the introduction ... United States. The color portable ultrasound unit provides outstanding ... for diagnostic use in numerous specialty markets. ... technologies to improve diagnostic confidence," said Ray Usukura, President ...
... Particle Sciences Inc. (PSI), a leading pharmaceutical ... of sterilizing medical devices.  The patent covers the notion ... the medical device.  Free radicals are, of course, an ... catheter coated with a free radical generating particle would, ...
Cached Medicine Technology:Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound System in the U.S. 2Particle Sciences Granted Patent on Self Sterilizing Medical Devices 2
(Date:8/29/2014)... 2014 - Despite US Preventive Services Task Force recommendations ... several of which may be ameliorated through technological approaches ... Langone Medical Center published online August 21, 2014 in ... JGIM ). , David Levine, MD, MA, a third ... NYU Langone, and colleagues found that compared to usual ...
(Date:8/29/2014)... August 29, 2014 According to ... begin accepting applications next month for medical marijuana, ... into accepting marijuana as a legalized medicine. New ... will be permitted to operate in accordance with ... be best suited to handle legal cannabis. ...
(Date:8/29/2014)... The microbiology testing sector is one of ... it is also the hugest challenge facing suppliers during ... spread of AIDS – still the world’s key health ... of opportunistic infections (OIs); bioterrorism threat; advancements in technologies ... medicines. Although for certain infections the etiology remains a ...
(Date:8/29/2014)... Floors of hospitals and other medical facilities ... many patients are relegated to lying down or sitting ... etc. Two inventors from Perrysburg, Ohio, have designed the ... This special pair of socks helps prevent slips and ... are relegated to beds or chairs from standing and ...
(Date:8/29/2014)... The 8th Annual Paint Columbus Pink® is a series of ... Contest, Light of Life Ceremony, Power in Prayer, Bright Pink ... all in support of cancer awareness. , Paint Columbus Pink ... Pink Foam and Obstacle Challenge on Saturday, October 4th, 2014 ... Georgia 31904. It will be the first foam and obstacle ...
Breaking Medicine News(10 mins):Health News:Options for weight loss your primary care doctor might not know about 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 2Health News:Infectious Disease Testing Universe Examined in New VPG Research Report Available at MarketPublishers.com 3Health News:Paint Columbus Pink Cancer Awareness/Kick-Off Meeting for Anyone Interested in Participating 2
... AMA Makes ,House Call, to Washington, Discusses New National Physician ... ... The American Medical,Association (AMA) National House Call campaign visits Washington today to,draw ... Medicare patients. Medicare plans to slash physician payments,10 percent on January 1, ...
... N.Y., Sept. 18 Lynn Clark,Callister, R.N., Ph.D., ... has joined the March of Dimes National Nurse ... nursing leaders who,give direction and counsel to March ... Dimes Nurse Advisory Council members represent the finest,maternal-child ...
... Insight Now(TM) automatically imports data from health plans, labs, ... ... health care actions, EATONTOWN, ... provider, has developed an on-line personal health,record with a built-in ...
... Sept. 18 ,The HealthCentral Network, Inc. ( ... today announced a collaboration leveraging,APF,s strength as ... with HealthCentral.com,s multimedia capabilities and extensive,online community ... officially,kicked off today with the posting of ...
... Suite operates with Gryphon compliance services ... in increased productivity for call centers, OKLAHOMA ... of,intelligent customer interaction solutions, today announced that it ... worldwide leader in,On-Demand Contact Governance solutions. This agreement ...
... Demand Entertainment Package for a ... Marks First LodgeNet Deployment in a Children,s Hospital, ... Corporation (Nasdaq: LNET ) and Children,s Hospital,of Pittsburgh ... "kid,friendly" LodgeNetRX Interactive Patient Television System, the company,s,first ever ...
Cached Medicine News:Health News:Medicare Cuts to Physicians Will Harm Washington Seniors 2Health News:Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council 2Health News:Triveris Introduces Personal Health Record with Built-in Health Advisor 2Health News:The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain 2Health News:The American Pain Foundation (APF) and The HealthCentral Network Collaborate to Develop Enhanced Internet Resources for People with Pain 3Health News:Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities 2Health News:Amcat Partners With Gryphon to Provide Comprehensive and Guaranteed Do Not Call (DNC) Compliance Solution for Outbound Contact Activities 3Health News:LodgeNet Deploys Customized 'Kid Friendly' Solution With Children's Hospital of Pittsburgh of UPMC 2Health News:LodgeNet Deploys Customized 'Kid Friendly' Solution With Children's Hospital of Pittsburgh of UPMC 3
EPO EIA Human Cytokines 021-SDX021 Erythropoietin Anemia...
... developed to detect the presence of ... The information is clinically useful in ... - a3 chain antibody formation along ... primary diagnostic parameters. Since there are ...
GBM -Ab EIA Auto-Immune Markers 013-GBM-96 Glomerular Basement Membrane...
...
Medicine Products: